alanine has been researched along with Ischemic Attack, Transient in 8 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Orbofiban, despite no significant excess risk of ICH, was not effective in preventing ischemic stroke or TIA." | 9.12 | Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. ( Cannon, CP; Feske, SK; Murphy, S; Schwamm, LH; Smith, EE, 2006) |
| " Orbofiban, despite no significant excess risk of ICH, was not effective in preventing ischemic stroke or TIA." | 5.12 | Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study. ( Cannon, CP; Feske, SK; Murphy, S; Schwamm, LH; Smith, EE, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Colaco, K | 1 |
| Lee, KA | 1 |
| Akhtari, S | 1 |
| Winer, R | 1 |
| Welsh, P | 1 |
| Sattar, N | 1 |
| McInnes, IB | 1 |
| Chandran, V | 1 |
| Harvey, P | 1 |
| Cook, RJ | 1 |
| Gladman, DD | 1 |
| Piguet, V | 1 |
| Eder, L | 1 |
| Smith, EE | 1 |
| Cannon, CP | 1 |
| Murphy, S | 1 |
| Feske, SK | 1 |
| Schwamm, LH | 1 |
| Conger, KA | 1 |
| Garcia, JH | 1 |
| Kauffman, FC | 1 |
| Lust, WD | 1 |
| Murakami, N | 1 |
| Passonneau, JV | 1 |
| Aureli, T | 1 |
| Miccheli, A | 1 |
| Di Cocco, ME | 1 |
| Ghirardi, O | 1 |
| Giuliani, A | 1 |
| Ramacci, MT | 1 |
| Conti, F | 1 |
| Moroni, F | 1 |
| Cozzi, A | 1 |
| Peruginelli, F | 1 |
| Carpenedo, R | 1 |
| Pellegrini-Giampietro, DE | 1 |
| Goodhardt, MJ | 1 |
| Strong, AJ | 1 |
| Bowen, DM | 1 |
| White, P | 1 |
| Branston, NM | 1 |
| Symon, L | 1 |
| Davison, AN | 1 |
| Kawakami, S | 1 |
| Kobayashi, K | 1 |
| Hossmann, KA | 1 |
| Kleihues, P | 1 |
| Matsumoto, K | 1 |
| Ueda, S | 1 |
| Hashimoto, T | 1 |
| Kuriyama, K | 1 |
1 trial available for alanine and Ischemic Attack, Transient
| Article | Year |
|---|---|
Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Topics: Aged; Alanine; Angina, Unstable; Aspirin; Cerebral Hemorrhage; Female; Fibrinolytic Agents; Follow-U | 2006 |
7 other studies available for alanine and Ischemic Attack, Transient
| Article | Year |
|---|---|
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis.
Topics: Adult; Alanine; Angina Pectoris; Apolipoproteins B; Arthritis, Psoriatic; Cardiovascular Diseases; C | 2021 |
Alanine: Glutamate ratios as an index of reversibility of cerebral ischemia in gerbils.
Topics: Alanine; Animals; Brain; Cyclic AMP; Gerbillinae; Glutamates; Ischemic Attack, Transient; Lactates | 1981 |
Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat--study by 13P- and 1H-NMR spectroscopy.
Topics: Acetylcarnitine; Adenosine Monophosphate; Adenosine Triphosphate; Alanine; Analysis of Variance; Ani | 1994 |
Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia.
Topics: Alanine; Animals; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Enzyme Inhibitors; Ge | 1999 |
The effects of middle-cerebral-artery occlusion on neurotransmitter metabolism in baboons.
Topics: Alanine; Aminobutyrates; Animals; Blood Pressure; Cerebral Cortex; gamma-Aminobutyric Acid; Haplorhi | 1977 |
[Recovery after complete cerebral ischemia: free amino acid levels in the brain tissue during and after complete cerebral ischemia (author's transl)].
Topics: Alanine; Amino Acids; Animals; Asparagine; Aspartic Acid; Brain Chemistry; Cats; gamma-Aminobutyric | 1978 |
Ischemic neuronal injury in the rat hippocampus following transient forebrain ischemia: evaluation using in vivo microdialysis.
Topics: Alanine; Amino Acids; Animals; Cell Survival; Dialysis; Evoked Potentials; gamma-Aminobutyric Acid; | 1991 |